Page last updated: 2024-09-03

reboxetine and Alcoholism

reboxetine has been researched along with Alcoholism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alen, F; Arco, R; Ballesta, A; Decara, J; Gómez de Heras, R; Orio, L; Pavón, FJ; Ramírez-López, M; Rodríguez de Fonseca, F; Serrano, A; Suárez, J; Vadas, E; Vargas, A1
Camarasa, X; Duboc, A; Khazaal, Y; Lopez-Martinez, E; Zullino, DF1

Trials

1 trial(s) available for reboxetine and Alcoholism

ArticleYear
Escitalopram/reboxetine combination in depressed patients with substance use disorder.
    Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1

    Topics: Adult; Alcoholism; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Combinations; Female; Humans; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Substance-Related Disorders

2005

Other Studies

1 other study(ies) available for reboxetine and Alcoholism

ArticleYear
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking.
    Addiction biology, 2021, Volume: 26, Issue:3

    Topics: Alcoholism; Animals; Drug-Seeking Behavior; Endocannabinoids; Glutamic Acid; Hippocampus; Male; Prefrontal Cortex; Rats; Rats, Wistar; Reboxetine; Self Administration; Signal Transduction; Substance Withdrawal Syndrome

2021